Dare Bioscience, Inc. 8-K

What Happened

• Daré Bioscience, Inc. (DARE) announced on April 22, 2026 that it made an updated corporate presentation available in the "Investors" section of its website (https://ir.darebioscience.com).
• The presentation dated April 22, 2026 is furnished as Exhibit 99.1 to the company’s Form 8-K filed the same day and is incorporated by reference under Regulation FD disclosure.

Key Details

• Presentation posted: April 22, 2026.
• Location: Investors section of Daré’s website (https://ir.darebioscience.com).
• Filing: Form 8-K dated April 22, 2026; Exhibit 99.1 = corporate presentation.
• The Form 8-K also includes the interactive XBRL cover page (Exhibit 104).

Why It Matters

• This filing alerts investors that Daré has publicly updated and distributed its corporate presentation under Regulation FD, which is the company’s formal way of sharing potentially material investor information with the market.
• Investors can review the posted presentation for the company’s latest corporate overview, strategy or program updates; the 8-K confirms the presentation is an official, filed disclosure.